FDA Strategic Plan Targets Bacteria Tied to Baby Formula Plant – Bloomberg Law

By Celine Castronuovo
The FDA is considering establishing a team dedicated to infant formula inspections to limit illnesses tied to strains of bacteria found at an Abbott infant formula facility that shut down earlier this year.
Susan Mayne, director of the Food and Drug Administration’s Center for Food Safety and Applied Nutrition, wrote in a blog post Wednesday that a new strategic plan from the agency aims to prevent future Cronobacter sakazakii illnesses linked to consumption of powdered infant formula.
The announcement comes as part of a wave of actions by the agency in the aftermath of reports of illnesses and deaths …
To read the full article log in.
Learn more about a Bloomberg Law subscription.



Learn More →

Leave a Reply

Your email address will not be published. Required fields are marked *